Crystal structures of zidovudine- or lamivudine-resistant human immunodeficiency virus type 1 reverse transcriptases containing mutations at codons 41, 184, and 215

被引：52
|
作者：
Chamberlain, PP
Ren, J
Nichols, CE
Douglas, L
Lennerstrand, J
Larder, BA
Stuart, DI
Stammers, DK
机构：
[1] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England
[2] Oxford Ctr Mol Sci, Oxford OX1 3QT, England
[3] Visible Genet, Cambridge CB4 0GA, England
来源：
JOURNAL OF VIROLOGY | 2002年 / 76卷 / 19期
关键词：
D O I：
10.1128/JVI.76.19.10015-10019.2002
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Six structures of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) containing combinations of resistance mutations for zidovudine (AZT) (M41L and T215Y) or lamivudine (M184V) have been determined as inhibitor complexes. Minimal conformational changes in the polymerase or nonnucleoside RT inhibitor sites compared to the mutant RTMC (D67N, K70P, T215F, and K219N) are observed, indicating that such changes may occur only with certain combinations of mutations. Model building M41L and T215Y into HIV-1 RT-DNA and docking in ATP that is utilized in the pyrophosphorolysis reaction for AZT resistance indicates that some conformational rearrangement appears necessary in RT for ATP to interact simultaneously with the M41L and T215Y mutations.
引用
收藏
页码：10015 / 10019
页数：5
相关论文
共 50 条
  • [21] Lamivudine can exert a modest antiviral effect against human immunodeficiency virus type 1 containing the M184V mutation
    Quan, YD
    Brenner, BG
    Oliveira, M
    Wainberg, MA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (02) : 747 - 754
  • [22] A novel human immunodeficiency virus type 1 reverse transcriptase mutational pattern confers phenotypic lamivudine resistance in the absence of mutation 184V
    Hertogs, K
    Bloor, S
    De Vroey, V
    Van den Eynde, C
    Dehertogh, P
    Van Cauwenberge, A
    Stürmer, M
    Alcorn, T
    Wegner, S
    Van Houtte, M
    Miller, V
    Larder, BA
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (03) : 568 - 573
  • [23] Fluorescent dye terminator sequencing methods for quantitative determination of replication fitness of human immunodeficiency virus type 1 containing the codon 74 and 184 mutations in reverse transcriptase
    Nurpeisov, V
    Hurwitz, SJ
    Sharma, PL
    JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (07) : 3306 - 3311
  • [24] Zidovudine-resistant human immunodeficiency virus type 1 strains subcultured in the presence of both lamivudine and quinoxaline HBY 097 retain marked sensitivity to HBY 097 but not to lamivudine
    Balzarini, J
    Pelemans, H
    Riess, G
    Roesner, M
    Winkler, I
    DeClercq, E
    Kleim, JP
    JOURNAL OF INFECTIOUS DISEASES, 1997, 176 (05): : 1392 - 1397
  • [25] A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multinucleoside analog resistance
    Larder, BA
    Bloor, S
    Kemp, SD
    Hertogs, K
    Desmet, RL
    Miller, V
    Sturmer, M
    Staszewski, S
    Ren, J
    Stammers, DK
    Stuart, DI
    Pauwels, R
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (08) : 1961 - 1967
  • [26] Broad nucleoside-analogue resistance implications for human immunodeficiency virus type 1 reverse-transcriptase mutations at codons 44 and 118
    Romano, L
    Venturi, G
    Bloor, S
    Harrigan, R
    Larder, BA
    Major, JC
    Zazzi, M
    JOURNAL OF INFECTIOUS DISEASES, 2002, 185 (07): : 898 - 904
  • [27] The Q207D reverse transcriptase mutation decreases zidovudine susceptibility and increases relative fitness of zidovudine-resistant human immunodeficiency virus type 1
    Lu, L
    Whitcomb, J
    Kuritzkes, DR
    ANTIVIRAL THERAPY, 2004, 9 (04) : U59 - U59
  • [28] Initial appearance of the 184Ile variant in lamivudine-treated patients is caused by the mutational bias of human immunodeficiency virus type 1 reverse transcriptase
    Keulen, W
    Back, NKT
    vanWijk, A
    Boucher, CAB
    Berkhout, B
    JOURNAL OF VIROLOGY, 1997, 71 (04) : 3346 - 3350
  • [29] Interaction of Reverse Transcriptase (RT) Mutations Conferring Resistance to Lamivudine and Etravirine: Effects on Fitness and RT Activity of Human Immunodeficiency Virus Type 1
    Hu, Zixin
    Kuritzkes, Daniel R.
    JOURNAL OF VIROLOGY, 2011, 85 (21) : 11309 - 11314
  • [30] YADD mutants of human immunodeficiency virus type 1 and Moloney murine leukemia virus reverse transcriptase are resistant to lamivudine triphosphate (3TCTP) in vitro
    Boyer, PL
    Gao, HQ
    Clark, PK
    Sarafianos, SG
    Arnold, E
    Hughes, SH
    JOURNAL OF VIROLOGY, 2001, 75 (14) : 6321 - 6328
12345